Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03563248
Title Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Massachusetts General Hospital
Indications

pancreatic adenocarcinoma

Therapies

Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin

Fluorouracil + Irinotecan + Leucovorin + Losartan + Oxaliplatin

Fluorouracil + Irinotecan + Leucovorin + Losartan + Nivolumab + Oxaliplatin

Fluorouracil + Irinotecan + Leucovorin + Nivolumab + Oxaliplatin

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.